About 422 million people worldwide have diabetes, according to the WHO, and most of them live in low- or middle-income ...

The "Semaglutides Market Report 2024" report has been added to ResearchAndMarkets.com's offering. This Semaglutides market report covers market characteristics, size and growth, segmentation, regional ...

A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...

McKinsey & Company’s 2024 Future of Wellness study – which surveyed more than 5,000 consumers across the United States, Britain and China – found that 82 per cent of U.S. respondents consider wellness ...

On the surface, the formula for weight loss seems simple: eat less and move more. But giving that advice to someone with ...

Researchers have found that polyphenols cause the secretion of hormones that may help lower a risk of developing type 2 ...

More than two billion people worldwide live with overweight or obesity, conditions closely linked to an array of health ...

Discover the inspiring weight loss journey of a dietitian who overcame PCOS and pregnancy challenges to achieve lasting ...

Here are 10 recent changes to colonoscopy laws, reimbursements and recommendations from 2024 that physicians should watch going into 2025: Beginning Jan. 1, Nebraska, Illinois, Kentucky and Vermont ...

A new study finds semaglutide is linked to an increased risk of vision loss associated with a rare eye condition, but cases ...

The Danish Medicines Agency requested the EMA's Pharmacovigilance Risk Assessment Committee review reports on the ...

These weight management drugs, which mimic natural hormones that regulate insulin and glucose levels, have become increasingly popular due to their effectiveness in promoting weight loss. However, ...